Epigenetic markers of prostate cancer in plasma circulating DNA. (Q45342371)

13 December 2017

Epigenetic markers of prostate cancer in plasma circulating DNA. (English)

1 reference

13 December 2017

Rene Cortese

1

0 references

Arvydas Laurinavicius

object named as

Arvydas Laurinavicius

12

0 references

Paul C. Boutros

object named as

Paul C Boutros

19

0 references

Sonata Jarmalaite

17

object named as

Sonata Jarmalaite

1 reference

13 December 2017

13

Feliksas Jankevicius

1 reference

13 December 2017

20

Arturas Petronis

1 reference

13 December 2017

Andrew Kwan

2

1 reference

13 December 2017

Emilie Lalonde

3

1 reference

13 December 2017

Olga Bryzgunova

4

1 reference

13 December 2017

Anna Bondar

5

1 reference

13 December 2017

Ying Wu

6

1 reference

13 December 2017

Juozas Gordevicius

7

1 reference

13 December 2017

Mina Park

8

1 reference

13 December 2017

Gabriel Oh

9

1 reference

13 December 2017

Zachary Kaminsky

10

1 reference

13 December 2017

Justina Tverkuviene

11

1 reference

13 December 2017

Dorota H S Sendorek

14

1 reference

13 December 2017

Syed Haider

15

1 reference

13 December 2017

Sun-Chong Wang

16

1 reference

13 December 2017

Pavel Laktionov

18

1 reference

13 December 2017

22 May 2012

1 reference

13 December 2017

Human Molecular Genetics

1 reference

13 December 2017

21

1 reference

13 December 2017

16

1 reference

13 December 2017

3619-3631

1 reference

Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?

13 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Screening for prostate cancer--the controversy that refuses to die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Advances in DNA methylation: 5-hydroxymethylcytosine revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

DNA methylation profiling of human chromosomes 6, 20 and 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

A decade of exploring the cancer epigenome - biological and translational implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Isolation and characterization of DNA from the plasma of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Exosome function: from tumor immunology to pathogen biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Current and emerging biomarkers in breast cancer: prognosis and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Progress in the development of prognostic and predictive markers for gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Differential methylation profile of ovarian cancer in tissues and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Molecular alterations in primary prostate cancer after androgen ablation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

In silico estimates of tissue components in surgical samples based on expression profiling data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Scanning Human Gene Deserts for Long-Range Enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Finding distal regulatory elements in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Biomarkers for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

DNA methylation based biomarkers in non-invasive cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Circulating nucleic acids as a potential source for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Prostate volume and adverse prostate cancer features: fact not artifact

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

The association of benign prostatic hyperplasia and cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

The role of epigenetics in aging and age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Management of cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Translating microarray data for diagnostic testing in childhood leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Convergent Random Forest predictor: methodology for predicting drug response from genome-scale data applied to anti-TNF response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Microarray-based DNA methylation profiling: technology and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Optimization of experimental design parameters for high-throughput chromatin immunoprecipitation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Statistical significance for genomewide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Linear mixed effects models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Adjusting batch effects in microarray expression data using empirical Bayes methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS192

21 January 2018

Identifiers

DOI

10.1093/HMG/DDS192

1 reference

13 December 2017

1 reference